首页>
外国专利>
USE OF BRADYCARDICA IN THE TREATMENT OF HYPERTROPHY-INCOMING MYOCARDIAL DISEASES AND NEW MEDICINAL COMBINATIONS
USE OF BRADYCARDICA IN THE TREATMENT OF HYPERTROPHY-INCOMING MYOCARDIAL DISEASES AND NEW MEDICINAL COMBINATIONS
展开▼
机译:芥末在肥大性心肌病和新药物合并治疗中的应用
展开▼
页面导航
摘要
著录项
相似文献
摘要
A medicament (A) for treating myocardial diseases associated with hypertrophy contains a bradycardic agent (I) and optionally another cardiac drug (II). ACTIVITY : Cardiant. In tests in a cat having severe hypertrophic cardiomyopathy, oral administration of cilobradine (Ia) twice daily at 0.3 mg/kg marked reduced the clinical symptoms (e.g. by reducing pain and normalizing the ECG) and also caused regression of the myocardial hypertrophy after 1 and 2 years. MECHANISM OF ACTION : Calcium ion channel blocker; beta -receptor blocker; i f channel blocker.
展开▼